Radiotherapy Market
Radiotherapy Market Size, Share and Industry Analysis Report By Type (External Beam Radiation Therapy, Internal Radiation Therapy and Systemic Radiation Therapy); By Technology (External Beam Radiotherapy, Internal Beam Radiotherapy/Brachytherapy and Systemic Radiotherapy); By Procedure (IMRT, IGRT, 3D-CRT, LDR and HDR); By Application (Prostate, Breast, Lung, Head, Neck Cancer, Colorectal Cancer and Other Cancers); By End User (Hospital, Clinics and Independent Radiotherapy Centers) - Forecast Year 2024 – 2031
Healthcare // Drug Delivery Devices
The global Radiotherapy
market is foreseen to grow by 5.7%, from USD 6.95 Billion in 2022 to USD 10.83
Billion in 2030. Technological advancements, increasing incidence of cancer
worldwide, awareness initiatives on the benefits of radiotherapy, growing use
of particle therapy for cancer treatment is to drive the market for the
upcoming forecast period. However, Inadequate healthcare infrastructure, shortage
of skilled oncologists and radiologists remains one factor hindering the market
growth over the anticipated period.
Market Definition
What Is Radiotherapy?
Market Overview
Types of
Radiotherapy
There are two
main types of radiotherapy: external beam radiation therapy and internal
radiation therapy. External beam radiation therapy involves using a machine
outside the body to deliver high-energy radiation to the cancer site. This type
of radiotherapy is the most common and can be used to treat almost any part of
the body. Internal radiation therapy, also known as brachytherapy, involves
placing a small amount of radioactive material inside the body near the cancer
site. This type of radiotherapy is commonly used to treat prostate cancer,
cervical cancer, and breast cancer.
Effectiveness
of Radiotherapy
Radiotherapy
can be a highly effective treatment for cancer. The effectiveness of
radiotherapy depends on several factors, including the type and stage of
cancer, the location of the cancer, and the overall health of the patient.
Radiotherapy can be used as the primary treatment for some cancers or as part
of a combination therapy. In some cases, radiotherapy may be used to shrink a
tumor before surgery or to kill any remaining cancer cells after surgery. The
goal of radiotherapy is to destroy cancer cells while minimizing damage to
healthy cells.
Side Effects of
Radiotherapy
Like any cancer
treatment, radiotherapy can cause side effects. The side effects of
radiotherapy depend on the location of the cancer and the amount of radiation
delivered. Common side effects include fatigue, skin irritation, nausea, and
diarrhea. These side effects are usually temporary and go away after treatment
is complete. However, in some cases, radiotherapy can cause long-term side
effects, such as infertility or an increased risk of developing a second
cancer.
Conclusion
Radiotherapy is
a powerful tool in the fight against cancer. It can be used alone or in
combination with other cancer treatments to destroy cancer cells and improve
patient outcomes. Although radiotherapy can cause side effects, most of these
are temporary and can be managed with medication and other therapies. If you or
a loved one has been diagnosed with cancer, talk to your doctor about whether
radiotherapy is an appropriate treatment option.
The expansion
of the radiotherapy market is being propelled by technological advancements and
an increasing prevalence of cancer. The market is also being driven by a
growing awareness of the advantages of radiotherapy and the amplified use of
particle therapy in cancer treatment. However, the development of this market
is being hindered by inadequate healthcare infrastructure, particularly in
emerging economies, and a shortage of qualified oncologists and radiologists.
Furthermore, the high cost of radiotherapy equipment and the complicated nature
of radiotherapy treatment are anticipated to curb the growth of this market in
the projected timeframe.
Radiotherapy
Market Dynamics
Radiotherapy is
gaining traction due to various initiatives aimed at creating awareness about
its benefits. Conferences and symposia, organized in recent years, have
emphasized spreading awareness about the advantages of radiotherapy for
treating a wide range of cancers. For instance, the 6th Cancer World Congress,
scheduled to be held in Portugal in September 2022, will focus on
"Personalized Cancer Diagnosis and Therapy." In May 2022, the 5th
Global Cancer Summit (GCS-2022) was held virtually with the theme "Living
with cancer in the 21st century" by BioGenesis Health Cluster and Global
Cancer Foundation.
These events
provide a platform to raise awareness and provide training for oncologists and
radiographers on radiotherapy procedures. The increased awareness about
available radiotherapy procedures and their benefits is expected to boost the
demand and adoption of radiotherapy devices.
Restraints in
Radiotherapy Market
One of the
restraints in the global radiotherapy market is the shortage of skilled
oncologists and radiologists. Despite continuous technological advancements,
the high standards required for effective radiotherapy can only be achieved and
maintained by experienced specialists. However, the shortage of trained
personnel and technical expertise is expected to hinder the implementation of
advanced radiotherapy techniques. This scarcity of skilled and trained
personnel results in many cancer patients missing out on effective radiotherapy
procedures, particularly in developing and underdeveloped countries.
In the United
States, the American Society of Clinical Oncologists (ASCO) reported that only
13,146 oncologists were engaged in active patient care in 2021. While some
cities have an abundance of oncologists, approximately 32 million Americans
reside in counties with no oncologists. According to ASCO, the shortage of
oncologists is projected to surpass 2,200 by 2025. Similarly, this lack of
skilled oncologists and radiologists is a challenge in several countries
worldwide, affecting the adoption of oncology procedures.
Opportunities
in Radiotherapy Market
One of the main
drivers of the global market growth is the increasing public-private
investments and funding for cancer research, which aims to improve the
diagnosis and treatment of cancer. Recent investments in radiotherapy solutions
by companies like Leo Cancer Care and government funding, such as the USD 45.5
million application for regional radiation treatment centers in Australia,
offer potential growth opportunities for market players.
Challenges in
Radiotherapy Market
However, a
major challenge faced during radiotherapy procedures is the difficulty in
visualizing tumors and distinguishing them from normal healthy tissues.
Although advancements in ionizing radiation therapy for cancer treatment can
help overcome this challenge, daily changes in tumor shape make it difficult to
only radiate the cancerous growth without affecting the surrounding tissues.
Radiologists often include a safety margin around the tumor and limit the
radiotherapy dose range to minimize damage to healthy tissue. As a result, the
number of treatment cycles required to eradicate tumorous cells increases,
which raises the treatment costs for patients undergoing radiotherapy.
Additionally, detecting tumor progression remains a clinical challenge, despite
technological advancements in imaging techniques. Due to these challenges,
oncologists prefer alternative treatment technologies like chemotherapy and
conventional surgical procedures.
The global
radiotherapy market is categorized into three technology segments: external
beam radiotherapy, internal beam radiotherapy/brachytherapy, and systemic
radiotherapy products. The external beam radiotherapy products segment includes
linear accelerators, particle therapy systems, and conventional cobalt-60
teletherapy units. The internal beam radiotherapy/brachytherapy products
segment comprises seeds, applicators, after loaders, and IORT systems. The
linear accelerators or LINAC segment is further divided into conventional LINAC
systems and stereotactic advanced electron/cobalt-60 LINAC systems, which
include the CyberKnife, Gamma Knife, and TomoTherapy sub-segments.
In 2021, the
cyberknife sub-segment within the stereotactic advanced electron/cobalt-60
linear accelerators segment accounted for the largest share of the global
radiotherapy market. This was attributed to the continuous development of the
CyberKnife system. For example, Accuray Incorporated launched the CyberKnife S7
System in June 2020, which is designed to deliver precise stereotactic
radiosurgery and stereotactic body radiation therapy treatments. Additionally,
several supply deals for the CyberKnife platform were made between 2018 and
2021 with various organizations such as Stanford University Medical Center,
Swiss Medical Network, and Mercy Advances Cancer Care. These developments are
expected to drive the adoption of the CyberKnife technology.
The external
beam radiotherapy segment is also seeing growth due to initiatives such as
conferences and symposia, which are raising awareness about the benefits of
radiotherapy procedures for a range of cancers. The 6th Cancer World Congress,
which is set to take place in Portugal in September 2022, has the theme of
"Personalized Cancer Diagnosis and Therapy," while the 5th Global
Cancer Summit was held virtually in May 2022 with the theme of "Living
with cancer in the 21st century." These events and others like them play a
crucial role in spreading awareness about the available radiotherapy procedures
and their benefits, ultimately leading to increased demand and adoption of
radiotherapy devices.
The Internal
Beam radiotherapy market is divided into several applications, including
prostate cancer, gynecological cancer, breast cancer, cervical cancer, penile
cancer, and other cancers. In 2022, the prostate cancer segment emerged as the
top application, capturing the highest market share. Prostate brachytherapy,
which involves the use of both LDR and HDR brachytherapy, is an advanced
treatment for prostate cancer. Globally, brachytherapy is increasingly being used
to treat high-risk prostate cancer either alone or in combination with hormone
therapy or EBRT. LDR brachytherapy, which delivers low-dose radiation and
protects surrounding healthy tissues, is as effective as prostatectomy or EBRT.
Additionally, brachytherapy obviates the need to monitor the prostate gland's
movement, as the radioactive seeds implanted move with the gland.
The External
Beam radiotherapy market is categorized into several procedures, including
IGRT, IMRT, stereotactic therapy, particle beam therapy, and 3D-CRT. The
particle therapy segment is predicted to experience the highest growth rate in
the external beam radiotherapy market by procedures during the forecast year.
This growth can be attributed to several factors, including the rising number
of proton therapy centers worldwide, increasing research activities in
radiation oncology with proton therapy systems, lower risks associated with
proton beam therapy, and a longer lifespan of proton beam therapy systems (30
years or more) as compared to photon therapy systems (10 years).
The global
radiotherapy market is segmented into five regions: North America, Europe, Asia
Pacific, Latin America, and the Middle East & Africa. The North American
market is further divided into the US and Canada. In 2022, the US held the
largest market share in North America, primarily driven by increasing awareness
about radiotherapy, a rising geriatric population, government initiatives in
the form of funds and grants for radiotherapy-related research and development,
and an increasing incidence of various cancers.
In FY 2021,
Siemens Healthineers AG became the leading player in the global market after
acquiring Varian Medical Systems, Inc. in April 2021. The acquisition resulted
in the company commanding the highest market share in the global radiotherapy
market, mainly due to the broad product portfolio of Varian Medical Systems,
Inc. and the combined sales and distribution capabilities of both companies. To
enhance its footprint in the global market, the company focuses on both organic
and inorganic growth strategies. Under Siemens Healthineers, Varian Medical
Systems, Inc. introduced and received regulatory approvals for several
products, including the ProBeam proton therapy system, ProBeam 360 with
multi-room configuration, and Halcyon system, in the last three years
(2019-2021). The company has also entered into several agreements,
partnerships, collaborations, and contracts to expand its market presence.
Market Segmentation
For the purpose
of this report, the global Radiotherapy market segmented on the basis of therapy
type, technology, procedure, application, end user, and region:
Therapy Type Outlook:
On the basis of
therapy type, the market is segmented into external beam radiation therapy,
internal radiation therapy, systemic radiation therapy.
Technology Outlook:
On the basis of
Technology, the market is segmented into External Beam Radiotherapy, Internal
Beam Radiotherapy/Brachytherapy, Systemic Radiotherapy. Further, External Beam
Radiotherapy is segmented into Linear Accelerators, Conventional Cobalt-60
Teletherapy Units, Particle Therapy Systems. Further, Internal Beam
Radiotherapy/Brachytherapy is segmented into Seeds, Afterloaders, Applicators,
IORT Systems. Further, Systemic Radiotherapy is segmented into Iobenguane
(I-131), Samarium-153, Rhenium-186 , Other Systemic Radiotherapy Products.
Procedure Outlook:
On the basis of
Procedure, the market is segmented into External Beam Radiotherapy, Internal
Beam Radiotherapy/Brachytherapy, Systemic Radiotherapy. Further, External Beam
Radiotherapy is segmented into Image-guided Radiotherapy, Intensity-modulated
Radiotherapy, Stereotactic Therapy, Particle Therapy, 3D Conformal Radiotherapy.
Further, Internal Beam Radiotherapy/Brachytherapy is segmented into
High-dose-rate Brachytherapy, Low-dose-rate Brachytherapy, Pulsed-dose-rate
Brachytherapy. Further, Systemic Radiotherapy is segmented into Intravenous
Radiotherapy, Oral Radiotherapy, Instillation Radiotherapy.
Figure 1 Radiotherapy Market By Procedure (Market
Size And Forecast By Value - USD Million, 2022 & 2030)
Application Outlook:
On the basis of
Application, the market is segmented into Prostate Cancer, Breast Cancer, Lung
Cancer, Head and Neck Cancer, Colorectal Cancer, Other Cancers.
End User Outlook:
On the basis of
end user, the market is segmented into hospital, independent radiotherapy centers.
Regional Outlook (Revenue, USD Million; 2022
& 2030)
|
Regional Outlook
(Revenue, USD Million; 2020-2030) |
|
|
North America |
U.S. |
|
Canada |
|
|
Europe |
Germany |
|
U.K. |
|
|
France |
|
|
Spain |
|
|
Italy |
|
|
Rest of the Europe |
|
|
Asia Pacific |
India |
|
Japan |
|
|
China |
|
|
South Korea |
|
|
Australia |
|
|
Rest of Asia-Pacific |
|
|
Middle East & Africa |
UAE |
|
Saudi Arabia |
|
|
South Africa |
|
|
Rest of Middle East & Africa |
|
|
Latin America |
Brazil |
|
Mexico |
|
|
Argentina |
|
|
Rest of Latin America |
|
Figure 2 Radiotherapy Market:
Regional Dynamics
An exclusive radiotherapy
market research report provides an in-depth analysis of the market dynamics
across five regions: North America, Europe, South America, Asia-Pacific, Middle
East, and Africa. Furthermore, the market has been evaluated by utilizing
diverse research methodologies and internal statistical model.
Companies Considered And Profiled In This
Market Study
The players
operating in the market have undertaken several strategies related to the
market in the period 2020-2022. some of the prominent players in the radiotherapy
market include
· Accuray
Incorporated
· BD
· Bebig Medical
· Elekta
· Hitachi Ltd.
· Iba Worldwide
· Icad, Inc.
· Intraop Medical,
Inc.
· Isoaid
· Isoray, Inc.
· Magnettx Oncology
Solutions Ltd.
· Mevion Medical
Systems
· Optivus Proton
Therapy, Inc.
· Panacea Medical
Technologies Pvt. Ltd.
· P-Cure
· Protom
International
· Provision
Healthcare
· Reflexion
· S.I.T. Sordina Iort
Technologies S.P.A.
· Sensus Healthcare
· Siemens
Healthineers Ag (Varian Medical Systems, Inc.)
· Sumitomo Heavy
Industry Ltd.
· Theragenics
· Viewray
Technologies, Inc.
· Zeiss Group
Global Radiotherapy Market Report Scope
|
Historical
data |
2020 - 2022 |
|
Base
year for estimation |
2022 |
|
Forecast
period |
2023 - 2030 |
|
Market
size value in 2022 |
USD 6.95
Billion |
|
Revenue
forecast in 2029 |
USD 10.83 Billion |
|
Growth
Rate |
CAGR of 5.7%
from 2022 to 2030 |
|
Quantitative
units |
Revenue in USD Million/Billion & CAGR
from 2023 to 2030 |
|
Report
coverage |
Revenue
forecast, company share, competitive landscape, growth factors, and trends |
|
Segments
covered |
Therapy Type, Technology, Procedure, End
User, Application |
|
Key
companies profiled |
Siemens
Healthineers Ag (Varian Medical Systems, Inc.), Elekta, Accuray Incorporated |
|
Regional
Scope |
North America, Europe, Asia Pacific, Middle
East & Africa, Latin America |
|
Country
Scope |
U.S.,
Canada, Germany, U.K., France, Italy, Spain, India, Japan, China, Australia,
South Korea, Saudi Arabia, UAE, South Africa, Brazil, Mexico, Argentina |
|
Customization
scope |
Free report customization (equivalent to up
to 8 analysts’ working days) with purchase. Addition or alteration to
country, regional & segment scope. |
Therapy Type Outlook (Revenue, USD Million/Billion;
2020-2030)
· External Beam
Radiation Therapy
· Internal Radiation
Therapy
· Systemic Radiation
Therapy
Technology Outlook (Revenue, USD
Million/Billion; 2020-2030)
· External Beam
Radiotherapy
o Linear Accelerators
o Conventional
Cobalt-60 Teletherapy Units
o Particle Therapy
Systems
· Internal Beam
Radiotherapy/Brachytherapy
o Seeds
o Afterloaders
o Applicators
o IORT Systems
· Systemic
Radiotherapy
o Iobenguane (I-131)
o Samarium-153
o Rhenium-186
o Other Systemic
Radiotherapy Products
Procedure Outlook (Revenue, USD
Million/Billion; 2020-2030)
· External Beam
Radiotherapy
o Image-guided
Radiotherapy
o Intensity-modulated
Radiotherapy
o Stereotactic
Therapy
o Particle Therapy
o 3D Conformal
Radiotherapy
· Internal Beam
Radiotherapy/Brachytherapy
o High-dose-rate
Brachytherapy
o Low-dose-rate
Brachytherapy
o Pulsed-dose-rate
Brachytherapy
· Systemic
Radiotherapy
o Intravenous
Radiotherapy
o Oral Radiotherapy
o Instillation
Radiotherapy
Application Outlook (Revenue, USD
Million/Billion; 2020-2030)
· Prostate Cancer
· Breast Cancer
· Lung Cancer
· Head and Neck
Cancer
· Colorectal Cancer
· Other Cancers
End User Outlook (Revenue, USD
Million/Billion; 2020-2030)
· Hospital
· Independent
Radiotherapy Centers
Regional Outlook (Revenue, USD
Million/Billion; 2020-2030)
· North America
o U.S.
o Canada
· Europe
o Germany
o U.K.
o France
o Spain
o Italy
o Rest of the Europe
· Asia Pacific
o India
o Japan
o China
o South Korea
o Australia
o Rest of
Asia-Pacific
· Middle East &
Africa
o UAE
o Saudi Arabia
o South Africa
o Rest of Middle East
& Africa
· Latin America
o Brazil
o Mexico
o Argentina
o Rest of Latin
America
Recent Developments In Radiotherapy Market:
Radiotherapy is
a critical component of cancer treatment, which involves using high-energy
radiation to destroy cancerous cells. The radiotherapy market has seen
significant growth in recent years, driven by advancements in technology and an
increasing prevalence of cancer worldwide. Here are some recent developments in
the radiotherapy market:
The
radiotherapy market has seen significant developments in recent years, with key
players launching innovative products. In June 2021, Elekta, a Swedish company,
received US FDA 510(k) clearance for its Elekta Harmony radiation therapy
system. This system offers advanced radiation therapy capabilities and can be
personalized to meet the needs of individual patients. Accuray Incorporated, a
US-based company, launched the CyberKnife S7 System in June 2020. This
innovative device combines speed, precision, and real-time AI-driven motion
tracking for stereotactic radiosurgery (SRS) and stereotactic body radiation
therapy (SBRT) treatments. Another major development was the release of Varian
Medical Systems, Inc.'s ProBeam 360° proton therapy system in September 2019.
This system is now available in a multi-room configuration, making it the
smallest multi-room system available for sale. These recent developments have
contributed to the growth of the radiotherapy market and have enabled
healthcare providers to offer more personalized and effective treatments to
patients.
Technological
advancements in radiotherapy equipment: The development of advanced
radiotherapy machines, such as linear accelerators and proton therapy systems,
has significantly improved the precision and efficacy of radiotherapy. These
machines offer greater accuracy in targeting cancer cells while minimizing
damage to healthy tissues.
Increased use
of image-guided radiotherapy: Image-guided radiotherapy (IGRT) is a technique
that uses imaging technologies, such as CT scans and MRI, to guide radiotherapy
treatment. IGRT enables physicians to precisely locate and target cancerous
cells, reducing the risk of damaging healthy tissues. The adoption of IGRT has
been increasing in recent years, driving growth in the radiotherapy market.
Rising demand
for personalized medicine: The demand for personalized medicine is on the rise,
and radiotherapy is no exception. Advancements in genomic testing and molecular
profiling have enabled physicians to tailor radiotherapy treatment to each
patient's specific genetic makeup and cancer type. This approach offers
improved outcomes and reduced side effects for patients.
Increasing
prevalence of cancer: Cancer is a leading cause of death worldwide, with the
number of cancer cases expected to increase in the coming years. This rising
prevalence of cancer is driving demand for radiotherapy treatments, as
radiotherapy is a key component of cancer treatment.
Growing focus
on patient-centric care: Patient-centric care has become a priority in the
healthcare industry, and the radiotherapy market is no exception. Radiotherapy
equipment manufacturers are increasingly focused on developing patient-friendly
machines that offer greater comfort, convenience, and safety for patients.
In conclusion,
the radiotherapy market has seen significant growth in recent years, driven by
advancements in technology and an increasing prevalence of cancer worldwide.
The development of advanced radiotherapy machines, the adoption of image-guided
radiotherapy, the demand for personalized medicine, the rising prevalence of
cancer, and the growing focus on patient-centric care are some of the recent
developments in the radiotherapy market.
|
Chapter
1. Introduction |
|
|
1.1. Market Definition |
|
|
1.2. Research Scope |
|
|
1.2.1. Markets Covered |
|
|
1.2.2. Years Considered for
Study |
|
|
Chapter 2. Executive
Summary |
|
|
2.1. Summary Snapshot Market Size
and Forecast, 2020-2030 |
|
|
2.2. Radiotherapy Market Share by
Therapy Type, 2022 vs 2030 (USD Million) |
|
|
2.3. Radiotherapy Market Share by Technology,
2022 vs 2030 (USD Million) |
|
|
2.4. Radiotherapy Market Share by
Procedure, 2022 vs 2030 (USD Million) |
|
|
2.5. Radiotherapy Market Share by
Application, 2022 vs 2030 (USD Million) |
|
|
2.5. Radiotherapy Market Share by End
User, 2022 vs 2030 (USD Million) |
|
|
2.6. Radiotherapy Market Share by
Region, 2022 vs 2030 (USD Million) |
|
|
Chapter 3. Key Insights |
|
|
Chapter 4. Radiotherapy
Market Segmentation & Impact Analysis |
|
|
4.1. Radiotherapy Market Indicators
Analysis |
|
|
4.1.1. Market Drivers
Analysis |
|
|
4.1.1.1.
Technological advancements |
|
|
4.1.1.2. Increasing
incidence of cancer worldwide |
|
|
4.1.2. Market Restraint
Analysis |
|
|
4.1.2.1. Inadequate
healthcare infrastructure |
|
|
4.1.3. Market Opportunity
Analysis |
|
|
4.1.3.1. Rising
healthcare expenditure across developing countries |
|
|
4.1.3.2. Increasing public-private
investments in cancer research |
|
|
4.2. Regulatory Analysis |
|
|
4.2.1. North America |
|
|
4.2.1.1. U.S. |
|
|
4.2.1.2. Canada |
|
|
4.2.2. Europe |
|
|
4.2.3. Asia Pacific |
|
|
4.2.3.1. India |
|
|
4.2.3.2. Japan |
|
|
4.2.3.3. China |
|
|
4.3. Technological Insights |
|
|
4.4. COVID-19 Impact analysis on
Radiotherapy Market |
|
|
4.5. Porter’s Five Forces Analysis |
|
|
4.5.1. Bargaining Power of
Buyers/Consumers |
|
|
4.5.2. Bargaining Power of
Suppliers |
|
|
4.5.3. Threat of New Entrants |
|
|
4.5.4. Threat of Substitute
Products |
|
|
4.5.5. Intensity of Competitive
Rivalry |
|
|
4.6. Competitive Metric Space Analysis |
|
|
Chapter 5. Radiotherapy
Market, By Therapy Type (Market Size and Forecast by Value - USD Million,
2020 - 2030) |
|
|
5.1. Radiotherapy Market, By Therapy
Type (Market Size and Forecast by Value - USD Million, 2022 & 2030) |
|
|
5.1.1. External Beam Radiation
Therapy |
|
|
5.1.1.1. External Beam Radiation Therapy Market
Estimates and Forecast, 2020-2030 (USD Million) |
|
|
5.1.1.2. External Beam Radiation Therapy Market
Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
|
5.1.2. Internal Radiation
Therapy |
|
|
5.1.2.1. Internal
Radiation Therapy Market Estimates and Forecast, 2020-2030 (USD Million) |
|
|
5.1.2.2. Internal Radiation
Therapy Market Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
|
5.1.3. Systemic Radiation
Therapy |
|
|
5.1.3.1. Systemic
Radiation Therapy Market Estimates and Forecast, 2020-2030 (USD Million) |
|
|
5.1.3.2. Systemic
Radiation Therapy Market Estimates and Forecast, By Region, 2020-2030 (USD
Million) |
|
|
Chapter
6. Radiotherapy Market, By Technology (Market Size and Forecast by Value
- USD Million, 2020 - 2030) |
|
|
6.1. Radiotherapy Market, By Technology
(Market Size and Forecast by Value - USD Million, 2022 & 2030) |
|
|
6.1.1. External Beam
Radiotherapy |
|
|
6.1.1.1. External Beam Radiotherapy Market Estimates
and Forecast, 2020-2030 (USD Million) |
|
|
6.1.1.2. External Beam Radiotherapy Market Estimates
and Forecast, By Region, 2020-2030 (USD Million) |
|
|
6.1.1.3. Linear Accelerators |
|
|
6.1.1.3.1. Linear Accelerators Market Estimates and Forecast,
2020-2030 (USD Million) |
|
|
6.1.1.3.2. Linear Accelerators Market Estimates and Forecast, By
Region, 2020-2030 (USD Million) |
|
|
6.1.1.3. Conventional Cobalt-60 Teletherapy Units |
|
|
6.1.1.3.1. Conventional Cobalt-60 Teletherapy Units Market Estimates
and Forecast, 2020-2030 (USD Million) |
|
|
6.1.1.3.2.
Conventional Cobalt-60 Teletherapy Units Market Estimates and Forecast, By
Region, 2020-2030 (USD Million) |
|
|
6.1.1.3. Particle Therapy Systems |
|
|
6.1.1.3.1. Particle Therapy Systems Market Estimates and Forecast,
2020-2030 (USD Million) |
|
|
6.1.1.3.2. Particle Therapy Systems Market Estimates and Forecast, By
Region, 2020-2030 (USD Million) |
|
|
6.1.2. Internal Beam
Radiotherapy/Brachytherapy |
|
|
6.1.2.1. Internal Beam Radiotherapy/Brachytherapy
Market Estimates and Forecast, 2020-2030 (USD Million) |
|
|
6.1.2.2. Internal Beam Radiotherapy/Brachytherapy
Market Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
|
6.1.1.3. Seeds |
|
|
6.1.1.3.1. Seeds Market Estimates and Forecast, 2020-2030 (USD
Million) |
|
|
6.1.1.3.2.
Seeds Market Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
|
6.1.1.3. Afterloaders |
|
|
6.1.1.3.1. Afterloaders Market Estimates and Forecast, 2020-2030 (USD
Million) |
|
|
6.1.1.3.2. Afterloaders Market Estimates and Forecast, By Region,
2020-2030 (USD Million) |
|
|
6.1.1.3. Applicators |
|
|
6.1.1.3.1. Applicators Market Estimates and Forecast, 2020-2030 (USD
Million) |
|
|
6.1.1.3.2. Applicators Market Estimates and Forecast, By Region,
2020-2030 (USD Million) |
|
|
6.1.1.3. IORT Systems |
|
|
6.1.1.3.1. IORT Systems Market
Estimates and Forecast, 2020-2030 (USD Million) |
|
|
6.1.1.3.2. IORT Systems Market Estimates and Forecast, By Region,
2020-2030 (USD Million) |
|
|
6.1.3. Systemic Radiotherapy |
|
|
6.1.3.1. Systemic
Radiotherapy Market Estimates and Forecast, 2020-2030 (USD Million) |
|
|
6.1.3.2. Systemic
Radiotherapy Market Estimates and Forecast, By Region, 2020-2030 (USD
Million) |
|
|
6.1.1.3. Iobenguane (I-131) |
|
|
6.1.1.3.1. Iobenguane (I-131) Market Estimates and Forecast, 2020-2030
(USD Million) |
|
|
6.1.1.3.2. Iobenguane (I-131) Market Estimates and Forecast, By
Region, 2020-2030 (USD Million) |
|
|
6.1.1.3. Samarium-153 |
|
|
6.1.1.3.1.
Samarium-153 Market Estimates and Forecast, 2020-2030 (USD Million) |
|
|
6.1.1.3.2. Samarium-153 Market Estimates and Forecast, By Region,
2020-2030 (USD Million) |
|
|
6.1.1.3. Rhenium-186 |
|
|
6.1.1.3.1. Rhenium-186 Market Estimates and Forecast, 2020-2030 (USD
Million) |
|
|
6.1.1.3.2. Rhenium-186 Market Estimates and Forecast, By Region,
2020-2030 (USD Million) |
|
|
6.1.1.3. Other Systemic Radiotherapy Products |
|
|
6.1.1.3.1. Other Systemic Radiotherapy Products Market Estimates and
Forecast, 2020-2030 (USD Million) |
|
|
6.1.1.3.2. Other Systemic Radiotherapy
Products Market Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
|
Chapter 7. Radiotherapy
Market, By Procedure (Market Size and Forecast by Value - USD Million, 2020 -
2030) |
|
|
7.1. Radiotherapy Market, By Procedure
(Market Size and Forecast by Value - USD Million, 2022 & 2030) |
|
|
7.1.1. External Beam
Radiotherapy |
|
|
7.1.1.1. External Beam Radiotherapy Market Estimates
and Forecast, 2020-2030 (USD Million) |
|
|
7.1.1.2. External Beam Radiotherapy Market Estimates
and Forecast, By Region, 2020-2030 (USD Million) |
|
|
7.1.2.3. Image-guided Radiotherapy |
|
|
7.1.2.3.1. Image-guided Radiotherapy Market Estimates and Forecast,
2020-2030 (USD Million) |
|
|
7.1.2.3.2. Image-guided Radiotherapy Market Estimates and Forecast, By
Region, 2020-2030 (USD Million) |
|
|
7.1.2.4. Intensity-modulated Radiotherapy |
|
|
7.1.2.4.1.
Intensity-modulated Radiotherapy Market Estimates and Forecast, 2020-2030
(USD Million) |
|
|
7.1.2.4.2. Intensity-modulated Radiotherapy Market Estimates and
Forecast, By Region, 2020-2030 (USD Million) |
|
|
7.1.2.5. Stereotactic Therapy |
|
|
7.1.2.7.1. Stereotactic Therapy Market Estimates and Forecast,
2020-2030 (USD Million) |
|
|
7.1.2.5.2. Stereotactic Therapy Market Estimates and Forecast, By
Region, 2020-2030 (USD Million) |
|
|
7.1.2.6. Particle Therapy |
|
|
7.1.2.6.1. Particle Therapy Market Estimates and Forecast, 2020-2030
(USD Million) |
|
|
7.1.2.6.2.
Particle Therapy Market Estimates and Forecast, By Region, 2020-2030 (USD
Million) |
|
|
7.1.2.7. 3D Conformal Radiotherapy |
|
|
7.1.2.7.1.
3D Conformal Radiotherapy Market Estimates and Forecast, 2020-2030 (USD
Million) |
|
|
7.1.2.7.2. 3D Conformal Radiotherapy Market Estimates and Forecast, By
Region, 2020-2030 (USD Million) |
|
|
7.1.2. Internal Beam
Radiotherapy/Brachytherapy |
|
|
7.1.2.1. Internal Beam Radiotherapy/Brachytherapy
Market Estimates and Forecast, 2020-2030 (USD Million) |
|
|
7.1.2.2. Internal Beam Radiotherapy/Brachytherapy
Market Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
|
7.1.2.3. High-dose-rate Brachytherapy |
|
|
7.1.2.3.1. High-dose-rate Brachytherapy Market Estimates and Forecast,
2020-2030 (USD Million) |
|
|
7.1.2.3.2. High-dose-rate Brachytherapy Market Estimates and Forecast,
By Region, 2020-2030 (USD Million) |
|
|
7.1.2.4. Low-dose-rate Brachytherapy |
|
|
7.1.2.4.1. Low-dose-rate
Brachytherapy Market Estimates and Forecast, 2020-2030 (USD Million) |
|
|
7.1.2.4.2. Low-dose-rate Brachytherapy Market Estimates and Forecast,
By Region, 2020-2030 (USD Million) |
|
|
7.1.2.5. Pulsed-dose-rate Brachytherapy |
|
|
7.1.2.7.1. Pulsed-dose-rate Brachytherapy Market Estimates and
Forecast, 2020-2030 (USD Million) |
|
|
7.1.2.5.2. Pulsed-dose-rate Brachytherapy Market Estimates and
Forecast, By Region, 2020-2030 (USD Million) |
|
|
7.1.3. Systemic Radiotherapy |
|
|
7.1.3.1. Systemic
Radiotherapy Market Estimates and Forecast, 2020-2030 (USD Million) |
|
|
7.1.3.2. Systemic
Radiotherapy Market Estimates and Forecast, By Region, 2020-2030 (USD
Million) |
|
|
7.1.2.3. Intravenous Radiotherapy |
|
|
7.1.2.3.1.
Intravenous Radiotherapy Market Estimates and Forecast, 2020-2030 (USD
Million) |
|
|
7.1.2.3.2. Intravenous Radiotherapy Market Estimates and Forecast, By
Region, 2020-2030 (USD Million) |
|
|
7.1.2.4. Oral Radiotherapy |
|
|
7.1.2.4.1. Oral Radiotherapy Market Estimates and Forecast, 2020-2030
(USD Million) |
|
|
7.1.2.4.2. Oral Radiotherapy Market Estimates and Forecast, By Region,
2020-2030 (USD Million) |
|
|
7.1.2.5. Instillation Radiotherapy |
|
|
7.1.2.7.1. Instillation Radiotherapy Market Estimates and Forecast,
2020-2030 (USD Million) |
|
|
7.1.2.5.2.
Instillation Radiotherapy Market Estimates and Forecast, By Region, 2020-2030
(USD Million) |
|
|
Chapter
8. Radiotherapy Market, By Application (Market Size and Forecast by
Value - USD Million, 2020 - 2030) |
|
|
8.1. Radiotherapy Market, By
Application (Market Size and Forecast by Value - USD Million, 2022 &
2030) |
|
|
8.1.1. Prostate Cancer |
|
|
8.1.1.1. Prostate Cancer Market Estimates and
Forecast, 2020-2030 (USD Million) |
|
|
8.1.1.2. Prostate Cancer Market Estimates and
Forecast, By Region, 2020-2030 (USD Million) |
|
|
8.1.2. Breast Cancer |
|
|
8.1.2.1. Breast Cancer Market Estimates and
Forecast, 2020-2030 (USD Million) |
|
|
8.1.2.2. Breast Cancer Market Estimates and
Forecast, By Region, 2020-2030 (USD Million) |
|
|
8.1.3. Lung Cancer |
|
|
8.1.3.1. Lung Cancer
Market Estimates and Forecast, 2020-2030 (USD Million) |
|
|
8.1.3.2. Lung Cancer
Market Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
|
8.1.4. Head and Neck Cancer |
|
|
8.1.4.1. Head and
Neck Cancer Market Estimates and Forecast, 2020-2030 (USD Million) |
|
|
8.1.4.2. Head and
Neck Cancer Market Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
|
8.1.5. Colorectal Cancer |
|
|
8.1.5.1. Colorectal Cancer Market Estimates and
Forecast, 2020-2030 (USD Million) |
|
|
8.1.5.2. Colorectal Cancer Market Estimates and
Forecast, By Region, 2020-2030 (USD Million) |
|
|
8.1.6. Other Cancers |
|
|
8.1.6.1. Other Cancers Market Estimates
and Forecast, 2020-2030 (USD Million) |
|
|
8.1.6.2. Other
Cancers Market Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
|
Chapter
9. Radiotherapy Market, By End User (Market Size and Forecast by Value -
USD Million, 2020 - 2030) |
|
|
9.1. Radiotherapy Market, By End User
(Market Size and Forecast by Value - USD Million, 2022 & 2030) |
|
|
9.1.1. Hospital |
|
|
9.1.1.1. Hospital Market Estimates and Forecast,
2020-2030 (USD Million) |
|
|
9.1.1.2. Hospital Market Estimates and Forecast, By
Region, 2020-2030 (USD Million) |
|
|
9.1.2. Independent Radiotherapy
Centers |
|
|
9.1.2.1.
Independent Radiotherapy Centers Market Estimates and Forecast,
2020-2030 (USD Million) |
|
|
9.1.2.2. Independent Radiotherapy Centers Market
Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
|
Chapter 10. Radiotherapy
Market, By Region (Market Size and Forecast by Value - USD Million, 2020 -
2030) |
|
|
10.1. Radiotherapy Market, By Region
(Market Size and Forecast by Value - USD Million, 2022 & 2030) |
|
|
10.2. North America |
|
|
10.2.1. North America
Radiotherapy Market, By Therapy Type, 2020-2030 (USD Million) |
|
|
10.2.2. North America
Radiotherapy Market, By Technology, 2020-2030 (USD Million) |
|
|
10.2.3. North America
Radiotherapy Market, By Procedure, 2020-2030 (USD Million) |
|
|
10.2.4. North America
Radiotherapy Market, By Application, 2020-2030 (USD Million) |
|
|
10.2.5. North America
Radiotherapy Market, By End User, 2020-2030 (USD Million) |
|
|
10.2.6. North America
Radiotherapy Market, By Country, 2020-2030 (USD Million) |
|
|
10.2.7. U.S. |
|
|
10.2.7.1. U.S.
Radiotherapy Market, By Therapy Type, 2020-2030 (USD Million) |
|
|
10.2.7.2. U.S. Radiotherapy
Market, By Technology, 2020-2030 (USD Million) |
|
|
10.2.7.3. U.S.
Radiotherapy Market, By Procedure, 2020-2030 (USD Million) |
|
|
10.2.7.4. U.S. Radiotherapy
Market, By Application, 2020-2030 (USD Million) |
|
|
10.2.7.5. U.S.
Radiotherapy Market, By End User, 2020-2030 (USD Million) |
|
|
10.2.8. Canada |
|
|
10.2.8.1. Canada
Radiotherapy Market, By Therapy Type, 2020-2030 (USD Million) |
|
|
10.2.8.2. Canada
Radiotherapy Market, By Technology, 2020-2030 (USD Million) |
|
|
10.2.8.3. Canada
Radiotherapy Market, By Procedure, 2020-2030 (USD Million) |
|
|
10.2.8.4. Canada
Radiotherapy Market, By Application, 2020-2030 (USD Million) |
|
|
10.2.8.5. Canada Radiotherapy
Market, By End User, 2020-2030 (USD Million) |
|
|
10.3. Europe |
|
|
10.3.1. Europe Radiotherapy
Market, By Therapy Type, 2020-2030 (USD Million) |
|
|
10.3.2. Europe Radiotherapy
Market, By Technology, 2020-2030 (USD Million) |
|
|
10.3.3. Europe Radiotherapy
Market, By Procedure, 2020-2030 (USD Million) |
|
|
10.3.4. EuropeRadiotherapy
Market, By Application, 2020-2030 (USD Million) |
|
|
10.3.5. EuropeRadiotherapy
Market, By End User, 2020-2030 (USD Million) |
|
|
10.3.6. Europe Radiotherapy
Market, By Country, 2020-2030 (USD Million) |
|
|
10.3.7. Germany |
|
|
10.3.7.1. Germany
Radiotherapy Market, By Therapy Type, 2020-2030 (USD Million) |
|
|
10.3.7.2. Germany
Radiotherapy Market, By Technology, 2020-2030 (USD Million) |
|
|
10.3.7.3. Germany
Radiotherapy Market, By Procedure, 2020-2030 (USD Million) |
|
|
10.3.7.4. Germany
Radiotherapy Market, By Application, 2020-2030 (USD Million) |
|
|
10.3.7.5. Germany
Radiotherapy Market, By End User, 2020-2030 (USD Million) |
|
|
10.3.8. U.K. |
|
|
10.3.8.1. U.K.
Radiotherapy Market, By Therapy Type, 2020-2030 (USD Million) |
|
|
10.3.8.2. U.K.
Radiotherapy Market, By Technology, 2020-2030 (USD Million) |
|
|
10.3.8.3. U.K.
Radiotherapy Market, By Procedure, 2020-2030 (USD Million) |
|
|
10.3.8.4. U.K.
Radiotherapy Market, By Application, 2020-2030 (USD Million) |
|
|
10.3.8.5. U.K.
Radiotherapy Market, By End User, 2020-2030 (USD Million) |
|
|
10.3.9. France |
|
|
10.3.9.1. France
Radiotherapy Market, By Therapy Type, 2020-2030 (USD Million) |
|
|
10.3.9.2. France
Radiotherapy Market, By Technology, 2020-2030 (USD Million) |
|
|
10.3.9.3. France
Radiotherapy Market, By Procedure, 2020-2030 (USD Million) |
|
|
10.3.9.4. France
Radiotherapy Market, By Application, 2020-2030 (USD Million) |
|
|
10.3.9.5. France Radiotherapy Market,
By End User, 2020-2030 (USD Million) |
|
|
10.3.10. Spain |
|
|
10.3.10.1. Spain Radiotherapy
Market, By Therapy Type, 2020-2030 (USD Million) |
|
|
10.3.10.2. Spain
Radiotherapy Market, By Technology, 2020-2030 (USD Million) |
|
|
10.3.10.3. Spain
Radiotherapy Market, By Procedure, 2020-2030 (USD Million) |
|
|
10.3.10.4. Spain
Radiotherapy Market, By Application, 2020-2030 (USD Million) |
|
|
10.3.10.5. Spain
Radiotherapy Market, By End User, 2020-2030 (USD Million) |
|
|
10.3.11. Italy |
|
|
10.3.11.1. Italy
Radiotherapy Market, By Therapy Type, 2020-2030 (USD Million) |
|
|
10.3.11.2. Italy
Radiotherapy Market, By Technology, 2020-2030 (USD Million) |
|
|
10.3.11.3. Italy
Radiotherapy Market, By Procedure, 2020-2030 (USD Million) |
|
|
10.3.11.4. Italy
Radiotherapy Market, By Application, 2020-2030 (USD Million) |
|
|
10.3.11.5. Italy
Radiotherapy Market, By End User, 2020-2030 (USD Million) |
|
|
10.3.12. Rest of Europe |
|
|
10.3.12.1. Rest of
Europe Radiotherapy Market, By Therapy Type, 2020-2030 (USD Million) |
|
|
10.3.12.2. Rest
of Europe Radiotherapy Market, By Technology, 2020-2030 (USD Million) |
|
|
10.3.12.3. Rest
of Europe Radiotherapy Market, By Procedure, 2020-2030 (USD Million) |
|
|
10.3.12.4. Rest
of Europe Radiotherapy Market, By Application, 2020-2030 (USD Million) |
|
|
10.3.12.5. Rest of
Europe Radiotherapy Market, By End User, 2020-2030 (USD Million) |
|
|
10.4. Asia Pacific |
|
|
10.4.1. Asia Pacific
Radiotherapy Market, By Therapy Type, 2020-2030 (USD Million) |
|
|
10.4.2. Asia Pacific
Radiotherapy Market, By Technology, 2020-2030 (USD Million) |
|
|
10.4.3. Asia Pacific
Radiotherapy Market, By Procedure, 2020-2030 (USD Million) |
|
|
10.4.4. Asia Pacific
Radiotherapy Market, By Application, 2020-2030 (USD Million) |
|
|
10.5.5. Asia Pacific
Radiotherapy Market, By End User, 2020-2030 (USD Million) |
|
|
10.4.6. Asia Pacific
Radiotherapy Market, By Country, 2020-2030 (USD Million) |
|
|
10.4.7. India |
|
|
10.4.7.1. India Radiotherapy
Market, By Therapy Type, 2020-2030 (USD Million) |
|
|
10.4.7.2. India
Radiotherapy Market, By Technology, 2020-2030 (USD Million) |
|
|
10.4.7.3. India
Radiotherapy Market, By Procedure, 2020-2030 (USD Million) |
|
|
10.4.7.4. India
Radiotherapy Market, By Application, 2020-2030 (USD Million) |
|
|
10.5.7.5. India
Radiotherapy Market, By End User, 2020-2030 (USD Million) |
|
|
10.4.8. Japan |
|
|
10.4.8.1. Japan
Radiotherapy Market, By Therapy Type, 2020-2030 (USD Million) |
|
|
10.4.8.2. Japan
Radiotherapy Market, By Technology, 2020-2030 (USD Million) |
|
|
10.4.8.3. Japan
Radiotherapy Market, By Procedure, 2020-2030 (USD Million) |
|
|
10.4.8.4. Japan
Radiotherapy Market, By Application, 2020-2030 (USD Million) |
|
|
10.5.8.5. Japan
Radiotherapy Market, By End User, 2020-2030 (USD Million) |
|
|
10.4.9. China |
|
|
10.4.9.1. China
Radiotherapy Market, By Therapy Type, 2020-2030 (USD Million) |
|
|
10.4.9.2. China
Radiotherapy Market, By Technology, 2020-2030 (USD Million) |
|
|
10.4.9.3. China
Radiotherapy Market, By Procedure, 2020-2030 (USD Million) |
|
|
10.4.9.4. China
Radiotherapy Market, By Application, 2020-2030 (USD Million) |
|
|
10.5.10.5. China Radiotherapy Market,
By End User, 2020-2030 (USD Million) |
|
|
10.4.10. South Korea |
|
|
10.4.10.1. South
Korea Radiotherapy Market, By Therapy Type, 2020-2030 (USD Million) |
|
|
10.4.10.2. South Korea Radiotherapy
Market, By Technology, 2020-2030 (USD Million) |
|
|
10.4.10.3. South
Korea Radiotherapy Market, By Procedure, 2020-2030 (USD Million) |
|
|
10.4.10.4. South
Korea Radiotherapy Market, By Application, 2020-2030 (USD Million) |
|
|
10.5.10.5. South
Korea Radiotherapy Market, By End User, 2020-2030 (USD Million) |
|
|
10.4.11. Australia |
|
|
10.4.11.1.
Australia Radiotherapy Market, By Therapy Type, 2020-2030 (USD Million) |
|
|
10.4.11.2.
Australia Radiotherapy Market, By Technology, 2020-2030 (USD Million) |
|
|
10.4.11.3. Australia
Radiotherapy Market, By Procedure, 2020-2030 (USD Million) |
|
|
10.4.11.4.
Australia Radiotherapy Market, By Application, 2020-2030 (USD Million) |
|
|
10.5.11.5.
Australia Radiotherapy Market, By End User, 2020-2030 (USD Million) |
|
|
10.4.12. Rest of Asia Pacific |
|
|
10.4.12.1. Rest
of Asia Pacific Radiotherapy Market, By Therapy Type, 2020-2030 (USD Million) |
|
|
10.4.12.2. Rest
of Asia Pacific Radiotherapy Market, By Technology, 2020-2030 (USD Million) |
|
|
10.4.12.3. Rest
of Asia Pacific Radiotherapy Market, By Procedure, 2020-2030 (USD Million) |
|
|
10.4.12.4. Rest
of Asia Pacific Radiotherapy Market, By Application, 2020-2030 (USD Million) |
|
|
10.5.12.5. Rest
of Asia Pacific Radiotherapy Market, By End User, 2020-2030 (USD Million) |
|
|
10.5. Middle East & Africa |
|
|
10.5.1. Middle East &
Africa Radiotherapy Market, By Therapy Type, 2020-2030 (USD Million) |
|
|
10.5.2. Middle East &
AfricaRadiotherapy Market, By Technology, 2020-2030 (USD Million) |
|
|
10.5.3. Middle East &
Africa Radiotherapy Market, By Procedure, 2020-2030 (USD Million) |
|
|
10.5.4. Middle East &
Africa Radiotherapy Market, By Application, 2020-2030 (USD Million) |
|
|
10.5.5. Middle East &
Africa Radiotherapy Market, By End User, 2020-2030 (USD Million) |
|
|
10.5.6. Middle East &
Africa Radiotherapy Market, By Country, 2020-2030 (USD Million) |
|
|
10.5.7. UAE |
|
|
10.5.7.1. UAE
Radiotherapy Market, By Therapy Type, 2020-2030 (USD Million) |
|
|
10.5.7.2. UAE Radiotherapy Market, By
Technology, 2020-2030 (USD Million) |
|
|
10.5.7.3. UAE
Radiotherapy Market, By Procedure, 2020-2030 (USD Million) |
|
|
10.5.7.4. UAE
Radiotherapy Market, By Application, 2020-2030 (USD Million) |
|
|
10.5.7.5. UAE
Radiotherapy Market, By End User, 2020-2030 (USD Million) |
|
|
10.5.8. Saudi Arabia |
|
|
10.5.8.1. Saudi
Arabia Radiotherapy Market, By Therapy Type, 2020-2030 (USD Million) |
|
|
10.5.8.2. Saudi
Arabia Radiotherapy Market, By Technology, 2020-2030 (USD Million) |
|
|
10.5.8.3. Saudi Arabia
Radiotherapy Market, By Procedure, 2020-2030 (USD Million) |
|
|
10.5.8.4. Saudi
Arabia Radiotherapy Market, By Application, 2020-2030 (USD Million) |
|
|
10.5.8.5. Saudi
Arabia Radiotherapy Market, By End User, 2020-2030 (USD Million) |
|
|
10.5.9. South Africa |
|
|
10.5.9.1. South
Africa Radiotherapy Market, By Therapy Type, 2020-2030 (USD Million) |
|
|
10.5.9.2. South
Africa Radiotherapy Market, By Technology, 2020-2030 (USD Million) |
|
|
10.5.9.3. South
Africa Radiotherapy Market, By Procedure, 2020-2030 (USD Million) |
|
|
10.5.9.4. South
Africa Radiotherapy Market, By Application, 2020-2030 (USD Million) |
|
|
10.5.9.5. South
Africa Radiotherapy Market, By End User, 2020-2030 (USD Million) |
|
|
10.5.10. Rest of Middle East
& Africa |
|
|
10.5.10.1. Rest
of Middle East & Africa Radiotherapy Market, By Therapy Type, 2020-2030
(USD Million) |
|
|
10.5.10.2. Rest
of Middle East & Africa Radiotherapy Market, By Technology, 2020-2030
(USD Million) |
|
|
10.5.10.3. Rest
of Middle East & Africa Radiotherapy Market, By Procedure, 2020-2030 (USD
Million) |
|
|
10.5.10.4. Rest
of Middle East & Africa Radiotherapy Market, By Application, 2020-2030
(USD Million) |
|
|
10.5.10.5. Rest
of Middle East & Africa Radiotherapy Market, By End User, 2020-2030 (USD
Million) |
|
|
10.6. Latin America |
|
|
10.6.1. Latin America Radiotherapy
Market, By Therapy Type, 2020-2030 (USD Million) |
|
|
10.6.2. Latin America
Radiotherapy Market, By Technology, 2020-2030 (USD Million) |
|
|
10.6.3. Latin America
Radiotherapy Market, By Procedure, 2020-2030 (USD Million) |
|
|
10.6.4. Latin America
Radiotherapy Market, By Application, 2020-2030 (USD Million) |
|
|
10.6.5. Latin America
Radiotherapy Market, By End User, 2020-2030 (USD Million) |
|
|
10.6.6. Latin America
Radiotherapy Market, By Country, 2020-2030 (USD Million) |
|
|
10.6.7. Brazil |
|
|
10.6.7.1. Brazil
Radiotherapy Market, By Therapy Type, 2020-2030 (USD Million) |
|
|
10.6.7.2. Brazil Radiotherapy
Market, By Technology, 2020-2030 (USD Million) |
|
|
10.6.7.3. Brazil
Radiotherapy Market, By Procedure, 2020-2030 (USD Million) |
|
|
10.6.7.4. Brazil
Radiotherapy Market, By Application, 2020-2030 (USD Million) |
|
|
10.6.7.5. Brazil
Radiotherapy Market, By End User, 2020-2030 (USD Million) |
|
|
10.6.8. Mexico |
|
|
10.6.8.1. Mexico Radiotherapy
Market, By Therapy Type, 2020-2030 (USD Million) |
|
|
10.6.8.2. Mexico
Radiotherapy Market, By Technology, 2020-2030 (USD Million) |
|
|
10.6.8.3. Mexico
Radiotherapy Market, By Procedure, 2020-2030 (USD Million) |
|
|
10.6.8.4. Mexico
Radiotherapy Market, By Application, 2020-2030 (USD Million) |
|
|
10.6.8.5. Mexico Radiotherapy
Market, By End User, 2020-2030 (USD Million) |
|
|
10.6.9. Argentina |
|
|
10.6.9.1.
Argentina Radiotherapy Market, By Therapy Type, 2020-2030 (USD Million) |
|
|
10.6.9.2.
Argentina Radiotherapy Market, By Technology, 2020-2030 (USD Million) |
|
|
10.6.9.3.
Argentina Radiotherapy Market, By Procedure, 2020-2030 (USD Million) |
|
|
10.6.9.4.
Argentina Radiotherapy Market, By Application, 2020-2030 (USD Million) |
|
|
10.6.9.5.
Argentina Radiotherapy Market, By End User, 2020-2030 (USD Million) |
|
|
10.6.10. Rest of Latin America |
|
|
10.6.10.1. Rest of
Latin America Radiotherapy Market, By Therapy Type, 2020-2030 (USD Million) |
|
|
10.6.10.2. Rest
of Latin America Radiotherapy Market, By Technology, 2020-2030 (USD Million) |
|
|
10.6.10.3. Rest
of Latin America Radiotherapy Market, By Procedure, 2020-2030 (USD Million) |
|
|
10.6.10.4. Rest
of Latin America Radiotherapy Market, By Application, 2020-2030 (USD Million) |
|
|
10.6.10.5. Rest
of Latin America Radiotherapy Market, By End User, 2020-2030 (USD Million) |
|
|
Chapter 11. Competitive Landscape |
|
|
11.1. Market Revenue Share by
Manufacturers |
|
|
11.2. Competitor’s Positioning |
|
|
11.3. Strategy Benchmarking |
|
|
11.3.1. Partnership &
Agreement |
|
|
11.3.2. New Product
Development |
|
|
11.3.3. Mergers &
Acquisitions |
|
|
11.3.4. Investment &
Expansion |
|
|
11.4. Vendor Landscape |
|
|
11.4.1. Distributors |
|
|
11.4.2. North America |
|
|
11.4.3. Europe |
|
|
11.4.4. Asia Pacific |
|
|
11.4.5. Middle East &
Africa |
|
|
11.4.6. Latin America |
|
|
11.5. Zettabyte Analytics Insights for
Competitive Landscape |
|
|
Chapter 12. Company
Profiles |
|
|
12.1. Accuray Incorporated |
|
|
12.1.1. Company Overview |
|
|
12.1.2. Products Offered |
|
|
12.1.3. Financials |
|
|
12.1.4. Recent
Development |
|
|
12.2. BD |
|
|
12.2.1. Company Overview |
|
|
12.2.2. Products Offered |
|
|
12.2.3. Financials |
|
|
12.2.4. Recent
Development |
|
|
12.3. Bebig Medical |
|
|
12.3.1. Company Overview |
|
|
12.3.2. Products Offered |
|
|
12.3.3. Financials |
|
|
12.3.4. Recent
Development |
|
|
12.4. Elekta |
|
|
12.4.1. Company Overview |
|
|
12.4.2. Products Offered |
|
|
12.4.3. Financials |
|
|
12.4.4. Recent
Development |
|
|
12.5. Hitachi Ltd. |
|
|
12.5.1. Company Overview |
|
|
12.5.2. Products Offered |
|
|
12.5.3. Financials |
|
|
12.5.4. Recent
Development |
|
|
12.6. Iba Worldwide |
|
|
12.6.1. Company Overview |
|
|
12.6.2. Products Offered |
|
|
12.6.3. Financials |
|
|
12.6.4. Recent
Development |
|
|
12.7. Icad, Inc. |
|
|
12.7.1. Company Overview |
|
|
12.7.2. Products Offered |
|
|
12.7.3. Financials |
|
|
12.7.4. Recent
Development |
|
|
12.8. Intraop Medical, Inc. |
|
|
12.8.1. Company Overview |
|
|
12.8.2. Products Offered |
|
|
12.8.3. Financials |
|
|
12.8.4. Recent
Development |
|
|
12.9. Isoaid |
|
|
12.9.1. Company Overview |
|
|
12.9.2. Products Offered |
|
|
12.9.3. Financials |
|
|
12.9.4. Recent
Development |
|
|
12.10. Isoray, Inc. |
|
|
12.10.1. Company Overview |
|
|
12.10.2. Products Offered |
|
|
12.10.3. Financials |
|
|
12.10.4. Recent
Development |
|
|
12.11. Magnettx Oncology Solutions Ltd. |
|
|
12.11.1. Company Overview |
|
|
12.11.2. Products Offered |
|
|
12.11.3. Financials |
|
|
12.11.4. Recent
Development |
|
|
12.12. Mevion Medical Systems |
|
|
12.12.1. Company Overview |
|
|
12.12.2. Products Offered |
|
|
12.12.3. Financials |
|
|
12.12.4. Recent
Development |
|
|
12.13. Optivus Proton Therapy, Inc. |
|
|
12.13.1. Company Overview |
|
|
12.13.2. Products Offered |
|
|
12.13.3. Financials |
|
|
12.13.4. Recent
Development |
|
|
12.14. Panacea Medical Technologies Pvt.
Ltd. |
|
|
12.14.1. Company Overview |
|
|
12.14.2. Products Offered |
|
|
12.14.3. Financials |
|
|
12.14.4. Recent
Development |
|
|
12.15. P-Cure |
|
|
12.15.1. Company Overview |
|
|
12.15.2. Products Offered |
|
|
12.15.3. Financials |
|
|
12.15.4. Recent
Development |
|
|
12.16. Protom International |
|
|
12.16.1. Company Overview |
|
|
12.16.2. Products Offered |
|
|
12.16.3. Financials |
|
|
12.16.4. Recent
Development |
|
|
12.17. Provision Healthcare |
|
|
12.17.1. Company Overview |
|
|
12.17.2. Products Offered |
|
|
12.17.3. Financials |
|
|
12.17.4. Recent
Development |
|
|
12.18. Reflexion |
|
|
12.18.1. Company Overview |
|
|
12.18.2. Products Offered |
|
|
12.18.3. Financials |
|
|
12.18.4. Recent Development |
|
|
12.19. S.I.T. Sordina Iort Technologies
S.P.A. |
|
|
12.19.1. Company Overview |
|
|
12.19.2. Products Offered |
|
|
12.19.3. Financials |
|
|
12.19.4. Recent
Development |
|
|
12.20. Sensus Healthcare |
|
|
12.20.1. Company Overview |
|
|
12.20.2. Products Offered |
|
|
12.20.3. Financials |
|
|
12.20.4. Recent
Development |
|
|
12.21. Siemens Healthineers Ag (Varian
Medical Systems, Inc.) |
|
|
12.21.1. Company Overview |
|
|
12.21.2. Products Offered |
|
|
12.21.3. Financials |
|
|
12.21.4. Recent
Development |
|
|
12.22. Sumitomo Heavy Industry Ltd. |
|
|
12.22.1. Company Overview |
|
|
12.22.2. Products Offered |
|
|
12.22.3. Financials |
|
|
12.22.4. Recent
Development |
|
|
12.23. Theragenics |
|
|
12.23.1. Company Overview |
|
|
12.23.2. Products Offered |
|
|
12.23.3. Financials |
|
|
12.23.4. Recent
Development |
|
|
12.24. Viewray Technologies, Inc. |
|
|
12.24.1. Company Overview |
|
|
12.24.2. Products Offered |
|
|
12.24.3. Financials |
|
|
12.24.4. Recent
Development |
|
|
12.25. Zeiss Group |
|
|
12.25.1. Company Overview |
|
|
12.25.2. Products Offered |
|
|
12.25.3. Financials |
|
|
12.25.4. Recent
Development |
|
|
Chapter 12. Research
Methodology |
|
|
12.1. Research Sources |
|
|
12.1.1. Primary |
|
|
12.1.2. Secondary |
|
|
12.12. Market Size Estimation |
|
|
Chapter 13. Appendix |
|
|
13.1. Discussion guide |
|
|
13.2. Knowledge Store:
Zettabyte Analytics Subscription Portal |
|
|
13.3. Available
Customizations |
|
|
13.4. Associated
Zettabyte Analytics Reports |
|
|
List of Tables |
|
|
Table 1 |
Radiotherapy Market, By
Therapy Type (Market Size and Forecast by Value - USD Million, 2022 &
2030) |
|
Table 2 |
External Beam Radiation
Therapy Market Estimates and Forecast, 2020-2030 (USD Million) |
|
Table 3 |
External Beam Radiation
Therapy Market Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
Table 4 |
Internal Radiation
Therapy Market Estimates and Forecast, 2020-2030 (USD Million) |
|
Table 5 |
Internal Radiation
Therapy Market Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
Table 6 |
Radiotherapy Market, By Technology
(Market Size and Forecast by Value - USD Million, 2022 & 2030) |
|
Table 7 |
External Beam
Radiotherapy Market Estimates and Forecast, 2020-2030 (USD Million) |
|
Table 8 |
External Beam
Radiotherapy Market Estimates and Forecast, By Region, 2020-2030 (USD
Million) |
|
Table 9 |
Radiotherapy Market, By
Procedure (Market Size and Forecast by Value - USD Million, 2022 & 2030) |
|
Table 10 |
External Beam
Radiotherapy Market Estimates and Forecast, 2020-2030 (USD Million) |
|
Table 11 |
External Beam
Radiotherapy Market Estimates and Forecast, By Region, 2020-2030 (USD
Million) |
|
Table 12 |
Internal Beam
Radiotherapy/Brachytherapy Market Estimates and Forecast, 2020-2030 (USD
Million) |
|
Table 13 |
Internal Beam
Radiotherapy/Brachytherapy Market Estimates and Forecast, By Region,
2020-2030 (USD Million) |
|
Table 14 |
Systemic Radiotherapy
Market Estimates and Forecast, 2020-2030 (USD Million) |
|
Table 15 |
Systemic Radiotherapy
Market Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
Table 16 |
Radiotherapy Market, By
Application (Market Size and Forecast by Value - USD Million, 2022 &
2030) |
|
Table 17 |
Prostate Cancer Market
Estimates and Forecast, 2020-2030 (USD Million) |
|
Table 18 |
Prostate Cancer Market
Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
Table 19 |
Breast Cancer Market
Estimates and Forecast, 2020-2030 (USD Million) |
|
Table 20 |
Breast Cancer Market
Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
Table 21 |
North America
Radiotherapy Market, By Therapy Type, 2020-2030 (USD Million) |
|
Table 22 |
North America
Radiotherapy Market, By Technology, 2020-2030 (USD Million) |
|
Table 23 |
North America
Radiotherapy Market, By Procedure, 2020-2030 (USD Million) |
|
Table 24 |
North America
Radiotherapy Market, By Application, 2020-2030 (USD Million) |
|
Table 25 |
North America
Radiotherapy Market, By Country, 2020-2030 (USD Million) |
|
Table 26 |
U.S. Radiotherapy Market,
By Therapy Type, 2020-2030 (USD Million) |
|
Table 27 |
U.S. Radiotherapy Market,
By Technology, 2020-2030 (USD Million) |
|
Table 28 |
U.S. Radiotherapy Market,
By Procedure, 2020-2030 (USD Million) |
|
Table 29 |
U.S. Radiotherapy Market,
By Application, 2020-2030 (USD Million) |
|
Table 30 |
Canada Radiotherapy
Market, By Therapy Type, 2020-2030 (USD Million) |
|
Table 31 |
Canada Radiotherapy
Market, By Technology, 2020-2030 (USD Million) |
|
Table 32 |
Canada Radiotherapy Market,
By Procedure, 2020-2030 (USD Million) |
|
Table 33 |
Canada Radiotherapy
Market, By Application, 2020-2030 (USD Million) |
|
Table 34 |
Europe Radiotherapy
Market, By Therapy Type, 2020-2030 (USD Million) |
|
Table 35 |
Europe Radiotherapy
Market, By Technology, 2020-2030 (USD Million) |
|
Table 36 |
Europe Radiotherapy
Market, By Procedure, 2020-2030 (USD Million) |
|
Table 37 |
EuropeRadiotherapy
Market, By Application, 2020-2030 (USD Million) |
|
Table 38 |
Europe Radiotherapy
Market, By Country, 2020-2030 (USD Million) |
|
Table 39 |
Germany Radiotherapy
Market, By Therapy Type, 2020-2030 (USD Million) |
|
Table 40 |
Germany Radiotherapy
Market, By Technology, 2020-2030 (USD Million) |
|
Table 41 |
Germany Radiotherapy Market,
By Procedure, 2020-2030 (USD Million) |
|
Table 42 |
Germany Radiotherapy
Market, By Application, 2020-2030 (USD Million) |
|
Table 43 |
U.K. Radiotherapy Market,
By Therapy Type, 2020-2030 (USD Million) |
|
Table 44 |
U.K. Radiotherapy Market,
By Technology, 2020-2030 (USD Million) |
|
Table 45 |
U.K. Radiotherapy Market,
By Procedure, 2020-2030 (USD Million) |
|
Table 46 |
U.K. Radiotherapy Market,
By Application, 2020-2030 (USD Million) |
|
Table 47 |
France Radiotherapy
Market, By Therapy Type, 2020-2030 (USD Million) |
|
Table 48 |
France Radiotherapy
Market, By Technology, 2020-2030 (USD Million) |
|
Table 49 |
France Radiotherapy
Market, By Procedure, 2020-2030 (USD Million) |
|
Table 50 |
France Radiotherapy Market,
By Application, 2020-2030 (USD Million) |
|
Table 51 |
Spain Radiotherapy
Market, By Therapy Type, 2020-2030 (USD Million) |
|
Table 52 |
Spain Radiotherapy
Market, By Technology, 2020-2030 (USD Million) |
|
Table 53 |
Spain Radiotherapy
Market, By Procedure, 2020-2030 (USD Million) |
|
Table 54 |
Spain Radiotherapy
Market, By Application, 2020-2030 (USD Million) |
|
Table 55 |
Italy Radiotherapy
Market, By Therapy Type, 2020-2030 (USD Million) |
|
Table 56 |
Italy Radiotherapy
Market, By Technology, 2020-2030 (USD Million) |
|
Table 57 |
Italy Radiotherapy
Market, By Procedure, 2020-2030 (USD Million) |
|
Table 58 |
Italy Radiotherapy
Market, By Application, 2020-2030 (USD Million) |
|
Table 59 |
Rest of Europe
Radiotherapy Market, By Therapy Type, 2020-2030 (USD Million) |
|
Table 60 |
Rest of Europe
Radiotherapy Market, By Technology, 2020-2030 (USD Million) |
|
Table 61 |
Rest of Europe
Radiotherapy Market, By Procedure, 2020-2030 (USD Million) |
|
Table 62 |
Rest of Europe
Radiotherapy Market, By Application, 2020-2030 (USD Million) |
|
Table 63 |
Asia Pacific Radiotherapy
Market, By Therapy Type, 2020-2030 (USD Million) |
|
Table 64 |
Asia Pacific Radiotherapy
Market, By Technology, 2020-2030 (USD Million) |
|
Table 65 |
Asia Pacific Radiotherapy
Market, By Procedure, 2020-2030 (USD Million) |
|
Table 66 |
Asia Pacific Radiotherapy
Market, By Application, 2020-2030 (USD Million) |
|
Table 67 |
Asia Pacific Radiotherapy
Market, By Country, 2020-2030 (USD Million) |
|
Table 68 |
India Radiotherapy
Market, By Therapy Type, 2020-2030 (USD Million) |
|
Table 69 |
India Radiotherapy
Market, By Technology, 2020-2030 (USD Million) |
|
Table 70 |
India Radiotherapy
Market, By Procedure, 2020-2030 (USD Million) |
|
Table 71 |
India Radiotherapy
Market, By Application, 2020-2030 (USD Million) |
|
Table 72 |
Japan Radiotherapy
Market, By Therapy Type, 2020-2030 (USD Million) |
|
Table 73 |
Japan Radiotherapy
Market, By Technology, 2020-2030 (USD Million) |
|
Table 74 |
Japan Radiotherapy
Market, By Procedure, 2020-2030 (USD Million) |
|
Table 75 |
Japan Radiotherapy
Market, By Application, 2020-2030 (USD Million) |
|
Table 76 |
China Radiotherapy
Market, By Therapy Type, 2020-2030 (USD Million) |
|
Table 77 |
China Radiotherapy
Market, By Technology, 2020-2030 (USD Million) |
|
Table 78 |
China Radiotherapy
Market, By Procedure, 2020-2030 (USD Million) |
|
Table 79 |
China Radiotherapy
Market, By Application, 2020-2030 (USD Million) |
|
Table 80 |
South Korea Radiotherapy
Market, By Therapy Type, 2020-2030 (USD Million) |
|
Table 81 |
South Korea Radiotherapy
Market, By Technology, 2020-2030 (USD Million) |
|
Table 82 |
South Korea Radiotherapy
Market, By Procedure, 2020-2030 (USD Million) |
|
Table 83 |
South Korea Radiotherapy
Market, By Application, 2020-2030 (USD Million) |
|
Table 84 |
Australia Radiotherapy
Market, By Therapy Type, 2020-2030 (USD Million) |
|
Table 85 |
Australia Radiotherapy
Market, By Technology, 2020-2030 (USD Million) |
|
Table 86 |
Australia Radiotherapy
Market, By Procedure, 2020-2030 (USD Million) |
|
Table 87 |
Australia Radiotherapy
Market, By Application, 2020-2030 (USD Million) |
|
Table 88 |
Rest of Asia Pacific
Radiotherapy Market, By Therapy Type, 2020-2030 (USD Million) |
|
Table 89 |
Rest of Asia Pacific
Radiotherapy Market, By Technology, 2020-2030 (USD Million) |
|
Table 90 |
Rest of Asia Pacific
Radiotherapy Market, By Procedure, 2020-2030 (USD Million) |
|
Table 91 |
Rest of Asia Pacific
Radiotherapy Market, By Application, 2020-2030 (USD Million) |
|
Table 92 |
Middle East & Africa
Radiotherapy Market, By Therapy Type, 2020-2030 (USD Million) |
|
Table 93 |
Middle East & Africa Radiotherapy
Market, By Technology, 2020-2030 (USD Million) |
|
Table 94 |
Middle East & Africa
Radiotherapy Market, By Procedure, 2020-2030 (USD Million) |
|
Table 95 |
Middle East & Africa
Radiotherapy Market, By Application, 2020-2030 (USD Million) |
|
Table 96 |
Middle East & Africa
Radiotherapy Market, By Country, 2020-2030 (USD Million) |
|
Table 97 |
UAE Radiotherapy Market,
By Therapy Type, 2020-2030 (USD Million) |
|
Table 98 |
UAE Radiotherapy Market,
By Technology, 2020-2030 (USD Million) |
|
Table 99 |
UAE Radiotherapy Market,
By Procedure, 2020-2030 (USD Million) |
|
Table 100 |
UAE Radiotherapy Market,
By Application, 2020-2030 (USD Million) |
|
Table 101 |
Saudi Arabia Radiotherapy
Market, By Therapy Type, 2020-2030 (USD Million) |
|
Table 102 |
Saudi Arabia Radiotherapy
Market, By Technology, 2020-2030 (USD Million) |
|
Table 103 |
Saudi Arabia Radiotherapy
Market, By Procedure, 2020-2030 (USD Million) |
|
Table 104 |
Saudi Arabia Radiotherapy
Market, By Application, 2020-2030 (USD Million) |
|
Table 105 |
South Africa Radiotherapy
Market, By Therapy Type, 2020-2030 (USD Million) |
|
Table 106 |
South Africa Radiotherapy
Market, By Technology, 2020-2030 (USD Million) |
|
Table 107 |
South Africa Radiotherapy
Market, By Procedure, 2020-2030 (USD Million) |
|
Table 108 |
South Africa Radiotherapy
Market, By Application, 2020-2030 (USD Million) |
|
Table 109 |
Rest of Middle East &
Africa Radiotherapy Market, By Therapy Type, 2020-2030 (USD Million) |
|
Table 110 |
Rest of Middle East &
Africa Radiotherapy Market, By Technology, 2020-2030 (USD Million) |
|
Table 111 |
Rest of Middle East &
Africa Radiotherapy Market, By Procedure, 2020-2030 (USD Million) |
|
Table 112 |
Rest of Middle East &
Africa Radiotherapy Market, By Application, 2020-2030 (USD Million) |
|
Table 113 |
Latin America
Radiotherapy Market, By Therapy Type, 2020-2030 (USD Million) |
|
Table 114 |
Latin America
Radiotherapy Market, By Technology, 2020-2030 (USD Million) |
|
Table 115 |
Latin America
Radiotherapy Market, By Procedure, 2020-2030 (USD Million) |
|
Table 116 |
Latin America
Radiotherapy Market, By Application, 2020-2030 (USD Million) |
|
Table 117 |
Latin America
Radiotherapy Market, By Country, 2020-2030 (USD Million) |
|
Table 118 |
Brazil Radiotherapy
Market, By Therapy Type, 2020-2030 (USD Million) |
|
Table 119 |
Brazil Radiotherapy
Market, By Technology, 2020-2030 (USD Million) |
|
Table 120 |
Brazil Radiotherapy
Market, By Procedure, 2020-2030 (USD Million) |
|
Table 121 |
Brazil Radiotherapy Market,
By Application, 2020-2030 (USD Million) |
|
Table 122 |
Mexico Radiotherapy
Market, By Therapy Type, 2020-2030 (USD Million) |
|
Table 123 |
Mexico Radiotherapy
Market, By Technology, 2020-2030 (USD Million) |
|
Table 124 |
Mexico Radiotherapy
Market, By Procedure, 2020-2030 (USD Million) |
|
Table 125 |
Mexico Radiotherapy
Market, By Application, 2020-2030 (USD Million) |
|
Table 126 |
Argentina Radiotherapy
Market, By Therapy Type, 2020-2030 (USD Million) |
|
Table 127 |
Argentina Radiotherapy
Market, By Technology, 2020-2030 (USD Million) |
|
Table 128 |
Argentina Radiotherapy
Market, By Procedure, 2020-2030 (USD Million) |
|
Table 129 |
Argentina Radiotherapy
Market, By Application, 2020-2030 (USD Million) |
|
Table 130 |
Rest of Latin America
Radiotherapy Market, By Therapy Type, 2020-2030 (USD Million) |
|
Table 131 |
Rest of Latin America
Radiotherapy Market, By Technology, 2020-2030 (USD Million) |
|
Table 132 |
Rest of Latin America
Radiotherapy Market, By Procedure, 2020-2030 (USD Million) |
|
Table 133 |
Rest of Latin America
Radiotherapy Market, By Application, 2020-2030 (USD Million) |
|
Table 134 |
Product Launch &
Development in The Radiotherapy Market, 2018-2021 |
|
Table 135 |
Investment and Expansion
in The Radiotherapy Market, 2020-2022 |
|
Table 136 |
Partnership &
Collaboration in The Radiotherapy Market, 2020-2022 |
|
Table 137 |
Merger & Acquisition
in The Radiotherapy Market, 2020-2022 |
|
List of Figures |
|
|
Figure 1 |
Research Methodology |
|
Figure 2 |
Summary Snapshot Market
Size and Forecast, USD Million, 2022 & 2030 |
|
Figure 3 |
Global Radiotherapy
Market Segmentation & Impact Analysis |
|
Figure 4 |
Regulatory Analysis |
|
Figure 5 |
COVID-19 Impact analysis
on Radiotherapy Market |
|
Figure 6 |
Market Revenue Share by
Manufacturers |
|
Figure 7 |
Radiotherapy Market, By
Therapy Type (Market Size and Forecast by Value - USD Million, 2022 &
2030) |
|
Figure 8 |
Radiotherapy Market, By Technology
(Market Size and Forecast by Value - USD Million, 2022 & 2030) |
|
Figure 9 |
Radiotherapy Market, By
Procedure (Market Size and Forecast by Value - USD Million, 2022 & 2030) |
|
Figure 10 |
Radiotherapy Market, By
Application (Market Size and Forecast by Value - USD Million, 2022 &
2030) |
|
Figure 11 |
Radiotherapy Market, By
Region (Market Size and Forecast by Value - USD Million, 2022 & 2030) |
1.
Research Sources
We at Zettabyte Analytics have a
detailed and related research methodology focussed on estimating the market
size and forecasted value for the given market. Comprehensive research
objectives and scope were obtained through secondary research of the parent and
peer markets. The next step was to validate our research by various market
models and primary research. Both top-down and bottom-up approaches were
employed to estimate the market. In addition to all the research reports, data
triangulation is one of the procedures used to evaluate the market size of
segments and sub-segments.
Research Methodology
1.1. Secondary Research
The secondary research study involves various sources and databases used
to analyze and collect information for the market-oriented survey of a specific
market. We use multiple databases for our exhaustive secondary research, such
as Factiva, Dun & Bradstreet, Bloomberg, Research article, Annual reports,
Press Release, and SEC filings of significant companies. Apart from this, a
dedicated set of teams continuously extracts data of key industry players and
makes an extensive and unique segmentation related to the latest market
development.
1.2. Primary Research
The primary research includes gathering data from specific domain
experts through a detailed questionnaire, emails, telephonic interviews, and
web-based surveys. The primary interviewees for this study include an expert
from the demand and supply side, such as CEOs, VPs, directors, sales heads, and
marketing managers of tire 1,2, and 3 companies across the globe.
1.3. Data Triangulation
The data triangulation is very important for any market study, thus we
at Zettabyte Analytics focus on at least three sources to ensure a high level
of accuracy. The data is triangulated by studying various factors and trends
from both supply and demand side. All the reports published and stored in our
repository follows a detailed process to obtain a reliable insight for our
clients.
1.4. In-House Verification
To validate the segmentation
and verify the data collected, our market expert ensures whether our research
analyst is considering fine distinction before analyzing the market.
1.5. Reporting
In the end,
presenting our research reports complied in a different format for straightforward
valuation such as ppt, pdf, and excel data pack is done.
+1 716 953 3077
sales@zettabyteanalytics.com
109 S Warren St, Syracuse, NY 13202, United States